TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
194,839
|
253,301
|
242,244 |
| Financial expenses |
2,042
|
796
|
7 |
| Earnings before taxes |
5,786
|
84,179
|
123,871 |
| EBITDA |
2,427
|
81,243
|
122,476 |
| Total assets |
96,273
|
184,924
|
178,869 |
| Current assets |
85,228
|
174,763
|
170,927 |
| Current liabilities |
46,057
|
81,269
|
53,683 |
| Equity capital |
41,615
|
96,884
|
120,733 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
20
|
17
|
11 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.2%
|
52.4%
|
67.5% |
| Turnover per employee |
9,742
|
14,900
|
22,022 |
| Profit as a percentage of turnover |
3.0%
|
33.2%
|
51.1% |
| Return on assets (ROA) |
8.1%
|
46.0%
|
69.3% |
| Current ratio |
185.0%
|
215.0%
|
318.4% |
| Return on equity (ROE) |
13.9%
|
86.9%
|
102.6% |
| Change turnover |
-58,462
|
11,057
|
75,714 |
| Change turnover % |
-23%
|
5%
|
45% |
| Chg. No. of employees |
3
|
6
|
5 |
| Chg. No. of employees % |
18%
|
55%
|
83% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.